Search Results 461-470 of 13777 for Unipen

  1. A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Crohn's Disease Who Completed the Studies M14-431 or M14-433 - Mayo Clinic

    A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Crohn's Disease Who Completed the Studies M14- ...

  2. Phase 1/2a Clinical Trial Of PR001 (LY3884961) In Patients With Parkinson's Disease With At Least One GBA1 Mutation (PROPEL)

    The purpose of this study is to evaluate the safety of intracisternal LY3884961 administration in patients with moderate to severe Parkinson's disease with at ...

  3. Benign peripheral nerve tumor - Doctors and departments - Mayo Clinic

    Learn more about the different types of tumors that grow on or around the nerves that link to the brain and spinal cord.

  4. Publications - Tito D. Pena Guzman, M.D. - Mayo Clinic

    Mohabbat AB, Salonen BR, Davis XD, Volcheck MM, Luedtke CA, Natividad LT, Pena Guzman TD, Johnson SM, Ledvina AJ, Merza CTL, Wight EC.

  5. A Study to Collect, Process, and Grow New Bone Cells from Human Pericranium - Mayo Clinic

    Can pericranium be used to regrow bone for the repair of critical mandibular defects? Participation eligibility. Participant eligibility includes age, gender, ...

  6. Peripheral nerve tumors - Doctors and departments - Mayo Clinic

    Learn about these growths that form in or near nerves connecting to the spinal cord. Surgery is the most common treatment.

  7. Peripheral nerve tumors - Doctors and departments - Mayo Clinic

    Learn about these growths that form in or near nerves connecting to the spinal cord. Surgery is the most common treatment.

  8. Univentricular Heart Clinical Trials - Mayo Clinic Research

    The purpose of this study is to determine if the medication, sildenafil (also known as Revatio), can slow or stop the progression of liver disease in patients ...

  9. Rene L. Utianski, Ph.D., CCC-SLP - Doctors and Medical Staff - Mayo Clinic

    The research interests of Rene L. Utianski, Ph.D., CCC-SLP include neurogenic motor speech disorders (the dysarthrias and apraxia of speech), ...

  10. ECOSPOR III - SER-109 Versus Placebo in the Treatment of Adults With Recurrent Clostridium Difficile Infection - Mayo Clinic

    About this study. Subjects will receive an oral dose of SER-109 in 4 capsules once daily for 3 consecutive days in Treatment Group I or matching placebo ...